# The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis

> **NCT00425451** · PHASE2 · COMPLETED · sponsor: **Dexcel Pharma Technologies Ltd.** · enrollment: 80 (actual)

## Conditions studied

- Periodontitis

## Interventions

- **DRUG:** PerioChip Plus (Flurbiprofen +Chlorhexidine ), Flurbiprofen Chip, PerioChip (Chlorhexidine ) and Placebo Chip

## Key facts

- **NCT ID:** NCT00425451
- **Lead sponsor:** Dexcel Pharma Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-01
- **Final completion:** 2009-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00425451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00425451, "The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00425451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*